General Information of the Compound
| Compound ID |
CP0475259
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)-N-[(4R)-1-methylsulfonyl-6-(naphthalen-2-ylmethyl)-3,4-dihydro-2H-quinolin-4-yl]propanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H36F3N3O6S
|
||||||||||||||||||
| Molecular Weight |
671.738
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C(F)(F)F.Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]1CCN(c2ccc(Cc3ccc4ccccc4c3)cc12)S(C)(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H35N3O4S.C2HF3O2/c1-20-14-26(36)15-21(2)27(20)19-29(33)32(37)34-30-12-13-35(40(3,38)39)31-11-9-23(18-28(30)31)16-22-8-10-24-6-4-5-7-25(24)17-22;3-2(4,5)1(6)7/h4-11,14-15,17-18,29-30,36H,12-13,16,19,33H2,1-3H3,(H,34,37);(H,6,7)/t29-,30+;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HQWWYBGVSJUSNR-XCCPJCIBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor